Study of IBI363 in Patients with Advanced First-line Gastric Cancer
Study of IBI363 in Patients with Advanced First-line Gastric Cancer
Recruiting · NCT06610799 · Registry updated 2024-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of IBI363 in Patients with Advanced First-line Gastric Cancer | IBI363 + Chemotherapy | Recruiting | Phase 1 | 2024-11-20 | NCT06610799 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xiangdong Cheng | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Cancer Hospital | Hangzhou | China | 21 |